3 Stocks Pushing The Health Care Sector Lower TheStreet.com Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care services related to the dialysis treatment a patient receives with end stage renal disease (ESRD); and other health care services. Fresenius Medical Care AG & Co. and more »

...

Fresenius Medical Care AG & Co. (NYSE:FMS) released its quarterly earnings data on Thursday. The company reported $0.79 EPS for the quarter, beating the consensus estimate of $0.43 by $0.36, Analyst Ratings Net reports. The business earned $4.20 billion during the quarter, compared to analysts’ expectations of $4.13 billion. The company’s quarterly revenue was up 15.0% on a year-over-year basis.

Fresenius Medical Care AG & Co. (NYSE:FMS) traded down 4.87% on Thursday, reaching $41.06. The company had a trading volume of 358,442 shares. Fresenius Medical Care AG & Co. has a 12 month low of $32.40 and a 12 month high of $44.34. The stock has a 50 day moving average of $42.66 and a 200 day moving average of $41.17. The firm has a market capitalization of $24.96 billion and a PE ratio of 23.75.

Separately, Commerzbank AG downgraded Fresenius Medical Care AG & Co. to a “hold” rating in a research note on Friday, May 29th. Six research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $37.03.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) is a kidney dialysis company. The Company provides dialysis care services related to the dialysis treatment a patient receives with end-stage renal disease (ESRD), as well as other health care services. FMC AG & CO. KGAA also provides dialysis products for the treatment of ESRD, which includes manufacturing and distributing products, such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. The Company’s health care services, referred to as care coordination services, include pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services and urgent care services. The Company also offers a range of dialysis drugs.

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

...

The new $300,000 dialysis unit at the Souris Hospital is not only more convenient for patient Nathan Bushey, it feels like a second home.

Three days a week Bushey, who is from Souris, spends four hours at a time receiving dialysis treatment. He calls it a full-time part-time job.

After the unit closed in 2014 due to water filtration system problems, Bushey and the other Souris dialysis patients were forced to travel to Charlottetown for treatment for nine months.

But after the community rallied, the new state-of-the-art unit was built.

It opened in March and will expand later this year to accommodate up to 12 patients a week.

Bushey describes how the unit has improved the quality of his treatment — and his life.

...

LAKEWOOD, Colo.--(BUSINESS WIRE)--Renal Ventures Management, LLC (RVM), a leading provider of dialysis services for patients suffering from end-stage renal disease (ESRD), completed construction of a new hemodialysis center in Flower Mound, Texas, and opened its doors to patients on July 8. Partnering with North Texas Kidney Disease Associates (NTKDA) to decide on a suitable location for the new center, RVM began construction of the Renal Center of Flower Mound in January 2015.

The Renal Center of Flower Mound, LLC features 13 heated hemodialysis chairs with free WI-FI, personal TVs and a café with coffee for patients. Operating under the supervision of Clinic Coordinator Marissa Dunlap, the center is currently accepting new hemodialysis patients looking for a comfortable, inviting treatment facility.

"We are excited to work with the community of Flower Mound, Texas, by providing high quality dialysis services in this beautiful, state-of-the-art center," said Renal Ventures Management Divisional Director, Tammy Jensen.

The opening of the center has been a well-coordinated effort among senior management, the operations department and third-party companies. The building also includes adjoining office space for the NTKDA nephrology practice.

At the Renal Center of Flower Mound, RVM implemented all of its quality programs, which continue to provide positive outcomes for patients. The programs include the RV Difference™, the framework for RVM's company culture; RV CARE™, which helps patients successfully transition to dialysis during the first 120 days; and RV Kidney Care, which provides ongoing education and support to chronic kidney disease patients.

The Renal Center of Flower Mound is located at 4941 Long Prairie Road, Flower Mound, TX 75028 and on the Web at www.renalcenterofflowermound.com.

About Renal Ventures Management, LLC

Renal Ventures Management LLC is a leading provider of dialysis services in the U.S. The company partners with hospitals and physicians to provide patients suffering from chronic kidney failure with knowledgeable, compassionate and quality-focused care in comfortable clinic settings. For its hospital and nephrologist partners, Renal Ventures Management provides management expertise and patient-focused care operations that center on collaboration, quality and effectiveness. Headquartered in Lakewood, Colo., the company operates 36 dialysis partnerships and 26 inpatient service contracts in six states. They also operate seven infusion centers in two states treating patients with various autoimmune disorders and a vascular access center in Lafayette, Louisiana. For more information, visit www.renalventures.com.

...